Podocyte globotriaosylceramide (GL-3) content in male adult patients with Fabry disease reduces following 6-12 months of treatment with migalastatBehzad Najafian,Alexey Sokolovskiy,Jay Barth,Jeff Castelli,Hadis Williams,Michael MauerMOLECULAR GENETICS AND METABOLISM（2016）引用 0|浏览7暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
